Search the site

Inert 50-nm Polystyrene Nanoparticles That Modify Pulmonary Dendritic Cell Function and Inhibit Allergic Airway Inflammation

Nanoparticles are being developed for diverse biomedical applications, but there is concern about potential to promote inflammation, particularly in the lungs.

Spring-infusors: How a simple and small solution can create king-sized complexity

The aims of the study were to investigate family and hospital staff views about the use of spring-infusor devices for administration of intravenous antibiotic medications, to examine if the device is acceptable and feasible and to map a process for implementation.

Implementation of a strategy to facilitate effective medical follow-up for Australian First Nations children hospitalised with lower respiratory tract infections: study protocol

First Nations children hospitalised with acute lower respiratory infections (ALRIs) are at increased risk of future bronchiectasis (up to 15-19%) within 24-months post-hospitalisation. An identified predictive factor is persistent wet cough a month after hospitalisation and this is likely related to protracted bacterial bronchitis which can progress to bronchiectasis, if untreated.

Primary Nasal Epithelial Cells as a Surrogate Cell Culture Model for Type-II Alveolar Cells to Study ABCA-3 Deficiency

ATP Binding Cassette Subfamily A Member 3 (ABCA-3) is a lipid transporter protein highly expressed in type-II alveolar (AT-II) cells. Mutations in ABCA3 can result in severe respiratory disease in infants and children. To study ABCA-3 deficiency in vitro, primary AT-II cells would be the cell culture of choice although sample accessibility is limited. Our aim was to investigate the suitability of primary nasal epithelial cells, as a surrogate culture model for AT-II cells, to study ABCA-3 deficiency.

New study to find COVID-fighting properties in existing medications thanks to national grant

Nearly 50 existing prescription medications already used by Australians will be tested by new research in the fight against COVID’s mutant variants.

300th participant recruited to crucial respiratory research program

A research program, which enables over 25 important respiratory research studies to be undertaken, celebrated the recruitment of its 300th participant on 14 December 2022.

Researchers share in almost $1.8 million for groundbreaking child health respiratory research

Three researchers from the Wal-yan Respiratory Research Centre will share in almost $1.8 million in grants to continue groundbreaking research to tackle childhood asthma prevention and lung disease.

Working with the community

Community involvement plays an integral role in guiding our research - find out how.

National Asthma Week: 10 things you need to know about asthma

Asthma affects about half a million Australian children and is one of the most common reasons why kids need to see a doctor or go to emergency.

Nationwide RSV program roll-out announced

More than two decades of research, modelling and collaboration to develop safe and effective RSV immunisations has led to a major Federal Government roll-out of a respiratory syncytial virus (RSV) immunisation program for all pregnant women and newborn babies in 2025.